Launch of Hysingla ER

The Federal Drug Administration (FDA) has approved the release of Hysingla ER, the first hard-to-abuse version of hydrocodone. Hysingla ER is an extended release opioid used to treat severe pain and should not be used for as-needed pain relief. The Hysingla ER tablet is labeled as having “abuse-deterrent properties”, which are expected to reduce, but not totally prevent, abuse of the drug when chewed and then taken orally, or crushed and snorted or injected.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com